Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
50%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 42 (66.7%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly

NCT06168773
unknownphase_4

Agents Intervening Against Delirium in Intensive Care Unit

NCT03392376
completedphase_4

Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After Laparoscopy

NCT05246631
completed

Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation

NCT03211897

Clinical Trials (4)

Showing 4 of 4 trials
NCT06168773Phase 2

Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly

Completed
NCT03392376Phase 4

Agents Intervening Against Delirium in Intensive Care Unit

Unknown
NCT05246631Phase 4

Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After Laparoscopy

Completed
NCT03211897

Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4